NIH-funded research R15 grant

Identifying genes that affect how amphetamines work in the brain

Official title: A Forward Genetic Screen to Identify Genes Involved in Amphetamine Action

Funded at Florida Atlantic University · NIH-11135886 · Data updated 2026-11-12

This study is looking at how amphetamines affect the brain and lead to addiction by using tiny worms to find out which genes play a role in these changes, and the goal is to help improve treatments for people struggling with addiction and ADHD.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionFlorida Atlantic University
NIH-funded
Lab location1 site (Boca Raton, United States)
Project startMay 15, 2025
Project endApril 30, 2028
Funding year2025
Award (this year)$571,675
NIH project number1R15DA062968-01
Project IDNIH-11135886 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with a history of amphetamine use or those diagnosed with ADHD.

Less likely to help

Patients who do not have a history of amphetamine use or ADHD may not receive direct benefits from this research.

What this research studies

This research investigates how amphetamines, commonly abused drugs, affect brain function and lead to addiction. By using a genetic screening approach with mutated strains of the model organism C. elegans, the researchers aim to identify specific genes that influence the response to amphetamines. The study will focus on understanding the physiological and behavioral changes that occur with amphetamine use, which could provide insights into addiction mechanisms. Patients may benefit from findings that could lead to better treatments for addiction and ADHD.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing and treating addiction to amphetamines and related disorders.

How similar studies have gone: While there has been significant research on addiction, this specific genetic screening approach using C. elegans is relatively novel and may provide new insights.

Where this research is happening

  • Florida Atlantic University
    Boca Raton, United States
    Active

Researchers

  • Principal investigator: Carvelli, Lucia — Florida Atlantic University
  • Study coordinator: Carvelli, Lucia

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.